Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads

NCT03045497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Perflutren Lipid Microspheres
DEVICE: Dynamic Contrast-Enhanced Ultrasound Imaging
DEVICE: Contrast-enhanced Magnetic Resonance Imaging

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University